USBU COVID-19 Supply Statement

In response to the many COVID-19 supply-related questions we’ve received from customers and patients, Takeda has updated its US COVID-19 Supply Statement as follows:

Based on current assessments of our global supply chain, we do not anticipate any potential supply disruption due to the Coronavirus outbreak. We are tracking the situation as it evolves and will take all necessary actions in an effort to ensure supply continuity for the patients we serve. And we will keep your health care providers and patient advocacy organizations informed of any material changes in status.